SUMO-mediated regulation of NLRP3 modulates inflammasome activity

179Citations
Citations of this article
132Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The NLRP3 inflammasome responds to infection and tissue damage, and rapidly escalates the intensity of inflammation by activating interleukin (IL)-1β, IL-18 and cell death by pyroptosis. How the NLRP3 inflammasome is negatively regulated is poorly understood. Here we show that NLRP3 inflammasome activation is suppressed by sumoylation. NLRP3 is sumoylated by the SUMO E3-ligase MAPL, and stimulation-dependent NLRP3 desumoylation by the SUMO-specific proteases SENP6 and SENP7 promotes NLRP3 activation. Defective NLRP3 sumoylation, either by NLRP3 mutation of SUMO acceptor lysines or depletion of MAPL, results in enhanced caspase-1 activation and IL-1β release. Conversely, depletion of SENP7 suppresses NLRP3-dependent ASC oligomerisation, caspase-1 activation and IL-1β release. These data indicate that sumoylation of NLRP3 restrains inflammasome activation, and identify SUMO proteases as potential drug targets for the treatment of inflammatory diseases.

Cite

CITATION STYLE

APA

Barry, R., John, S. W., Liccardi, G., Tenev, T., Jaco, I., Chen, C. H., … Meier, P. (2018). SUMO-mediated regulation of NLRP3 modulates inflammasome activity. Nature Communications, 9(1). https://doi.org/10.1038/s41467-018-05321-2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free